Precision Medicine Online

Precision Medicine Online Precision Medicine Online is published by GenomeWeb, an independent online news organization.

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of b...
10/20/2025

As Novartis moves ahead plans to expand Pluvicto's use based on the PSMAddition trial, experts urge for greater use of biomarkers to identify best responders.

Researchers at the ESMO Congress said they want to confirm their findings in a prospective randomized controlled trial.
10/19/2025

Researchers at the ESMO Congress said they want to confirm their findings in a prospective randomized controlled trial.

Patients with a very rare immune disorder who have gotten the gene therapy have experienced sustained long-term immune p...
10/16/2025

Patients with a very rare immune disorder who have gotten the gene therapy have experienced sustained long-term immune protection, according to data published in NEJM.

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...
10/16/2025

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate providers to think more about biomarkers first.

Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is apply...
10/14/2025

Two recent studies identified gene knockouts that may make CAR T-cell therapy more effective, but the next step is applying the hypotheses in humans.

The firm continues to seek needed funds to launch a Phase I/II trial of ELP-02 for this extremely rare form of Charcot-M...
10/09/2025

The firm continues to seek needed funds to launch a Phase I/II trial of ELP-02 for this extremely rare form of Charcot-Marie-Tooth disease.

The initiative comprises academic institutions, charities, and companies pursuing a broad range of novel diagnostic and ...
10/08/2025

The initiative comprises academic institutions, charities, and companies pursuing a broad range of novel diagnostic and therapeutic approaches.

The company expects topline results in 2026 from this group of the basket trial testing the drug plixorafenib as a next-...
10/07/2025

The company expects topline results in 2026 from this group of the basket trial testing the drug plixorafenib as a next-generation monotherapy.

Some genetics experts felt the event raised awareness of the importance of testing, while others had mixed feelings amid...
10/02/2025

Some genetics experts felt the event raised awareness of the importance of testing, while others had mixed feelings amid growing healthcare access worries.

The researchers are hopeful that prenatal screening using BillionToOne's Unity Screen test could allow for important stu...
10/01/2025

The researchers are hopeful that prenatal screening using BillionToOne's Unity Screen test could allow for important studies of this strategy in cystic fibrosis and beyond.

The drugmaker is transitioning to Trialbee's Honey platform to better screen patients, including for biomarker informati...
10/01/2025

The drugmaker is transitioning to Trialbee's Honey platform to better screen patients, including for biomarker information, before sending them to trial sites.

The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to p...
09/30/2025

The study found that patients with luminal B subtype prostate cancer benefited from the addition of hormone therapy to post-surgery radiation.

Address

New York, NY

Telephone

+12122694747

Website

Alerts

Be the first to know and let us send you an email when Precision Medicine Online posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Precision Medicine Online:

Shortcuts

Share

Category